ArticleFrontiers in oncology2021

Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a

Benoît Brethon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.